Harmony Biosciences Holdings, Inc. (HRMY): Net Income
$158.69M
Year ended 2025-12-31
$181.27M
Trailing 12 months to 2026-06-30
-4.4%
3-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $158.69M | +9.1% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $145.49M | +12.9% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $128.85M | -29.0% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $181.47M | +424.5% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $34.60M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | -$36.94M | n/m | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | -$151.98M | n/a | 2022-02-28, From 2019-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $158.69M | +9.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $78.34M | n/m |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $30.11M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$381.39M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$288.28M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $62.87M | -9.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $99.65M | -29.4% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $52.60M | n/m |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $7.03M | n/m |
Compare HRMY, ANIP, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗